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Abstract: An unexpected ring-closing reaction of an ,-unsaturated 
carboxylic acid, derived from (R)- and -(S)-limonene, in the presence 
of trifluoroacetic anhydride (TFAA) resulted in bicyclic α-methylene 
ketones and their hydroxylated analogues in a stereoselective 
intramolecular acylation. The reaction was studied in detail and 
optimized for both compounds. Addition of secondary and primary 
amines to both keto alkenes followed by in situ reduction of formed 
aminoketones with sodium borohydride gave new bicyclic terpenoid 
secondary and tertiary 1,3-aminoalcohols and aminodiols with 
excellent diastereoselectivity. Regioisomeric aminodiols were 
prepared stereoselectively from the unsaturated 1,3-aminoalcohols 
via hydroboration reaction with Me2S. BH3/H2O2 system. 
Introduction 
Cyclic chiral aminoalcohols have many important applications in 
chiral catalysis[1-8] and in the synthesis of biologically active 
compounds as building blocks.[9,10] Many monoterpenes, such as 
(+)-pulegone,[1] (+)- and (-)-3-carane,[2,3] as well as (+)- and (-)-α-
pinene,[4] have been widely used as starting materials for the 
synthesis of various aminoalcohols, which are applied as chiral 
additives and catalysts in several chemical transformations.[1-3,9] 
Monoterpene-based 1,2- and 1,3-aminoalcohols, prepared 
stereoselectively from commercially available monoterpenes, 
have proven to be excellent catalysts in a wide range of 
stereoselective reactions including catalytic asymmetric carbon-
carbon bond formation, dialkylzinc addition to aldehydes, and 
asymmetric allylic alkylation.[5-8,10] 
Chiral aminodiols, which combine the chemical properties of 1,2- 
and 1,3-aminoalcohols, have also been widely used as chiral 
auxiliaries in enantioselective syntheses.[11-15] Moreover, they are 
excellent building blocks for the synthesis of versatile heterocyclic 
compounds depending upon the participation of specific hydroxyl 
groups in ring closure with the amino group. Aminodiols proved to 
be excellent starting materials for the synthesis of both 1,3-
oxazines and spiro 1,3-heterocycles.[1,12,16] Since the resulting 
heterocycles contain a free hydroxyl group having coordinating 
ability, this may give rise to greater rigidity within a transition state, 
and hence to higher enantioselective induction in asymmetric 
transformations.[3] Aminodiols also serve as substrates for the 
synthesis of biologically active natural compounds (cytoxazone, 
etc.), while others exhibit significant biological activities 
(aristeromycin, etc.).[11,17] 
Monoterpene-based aminodiols were also found to be excellent 
starting materials for the synthesis of nucleoside analogues with 
remarkable sodium/calcium exchanger (NCX) inhibitor 
activity.[18,19] 
In our present work we report the preparation of limonene-based 
chiral 1,3-aminoalcohols and aminodiols, a new family of bi- and 
tri-functional terpenoids starting from commercially available (-)- 
and (+)-limonene via stereoselective transformations. 
Results and Discussion 
Starting from commercially available (-)-(S)-limonene 1, key 
intermediate bicyclic methylene ketones (-)-5 and (-)-6 were 
prepared in a four-step synthesis. (-)-1 was metalated by 
treatment with the strong base n-butyllithium/TMEDA,[20-22] 
followed by trimethoxyborane treatment to produce a boron-
substituted limonenyl derivative. Then boron was removed by 
hydrogen peroxide as oxidizing agent to produce (S)-p-mentha-
1,8-dien-9-ol (-)-2 bearing a hydroxyl group at position 10. 
Metalation is not selective,[20] resulting in (S)-perillylalcohol as well. 
Unfortunately, separation of the regioisomeric alcohols was 
unsuccessfull in a gram scale. Consequently, MnO2 was used to 
oxidize the mixture of alcohols to (S)-perillaldehyde and (S)-p-
mentha-1,8-dien-9-al (-)-3, which were easily separated by 
column chromatography. (-)-3 was then converted to carboxylic 
acid (-)-4 using a literature method (Scheme 1).[23-25] 
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Scheme 1. Synthesis of bicyclic methylene ketones (-)-5 and (-)-6. 
When (S)-isoperyllic acid (-)-4 was then treated with (CF3CO)2O 
(TFAA) in dry toluene to prepare the corresponding tert-butyl ester, 
an unexpected intramolecular ring closing reaction[23,24] was 
observed resulting in two products: methylene ketone (-)-6 and its 
hydroxyl-substituted analogue (-)-5 (Scheme 1). It is interesting to 
note, that although both keto alkenes are new compounds, similar 
structures can be found in the structure of cytotoxic kaurane-type 
natural diterpenoids[26] and a partially saturated analogue of 6 is 
also known to be a natural component of Japanese sour citrus 
fruits.[27] The temperature strongly affected the yield and the ratio 
of the two products. At low temperature (0 °C), formation of the 
kinetically controlled 5 was observed as the main product, 
whereas at 25 °C the products were formed in a ratio of 1:1. In 
contrast, the thermodynamically preferred 6 was obtained as a 
single product at 100 °C. [28] At lower temperature, the yield of the 
reaction dropped dramatically without any remarkable changes in 
the 5:6 ratio (Table 1). When other solvents, acid catalyst or acetic 
anhydride was applied, the reaction failed. 
 
Table 1. Cyclisation reaction of (S)-isoperyllic acid (4). 
Entry Solvent Additive T [°C] t [h] Ratio 
[5:6] [a] 
Yield 
[%][b] 
1 toluene TFAA 25 12 55:45 91 
2 toluene Ac2O 25 48 - - 
3 MeCN TFAA 25 48 - - 
4 AcOH - 25 48 - - 
5 toluene TFAA 0 48 67:33 80 
6 toluene TFAA -20 >48 67:33 40 
7 toluene TFAA 100 6 0:100 56 
[a] Based on 1H-NMR measurements. [b] Isolated, combined yield of 5 and 
6. 
The reaction between the carboxylic acid and the double bond in 
the presence of TFAA can be interpreted by a carbonium ion 
mechanism (Scheme 2).[28,29] In the first step, acylium ion 4A is 
formed upon the attack of TFAA to the carboxylic acid group 
followed by an intramolecular attack on the olefinic bond to yield 
carbonium ion 4B. The latter loses the γ-proton to form ketone 6 
or reacts with the trifluoroacetate anion to yield ester 4C, which 
undergoes hydrolysis under work-up conditions to deliver 5.[28] 
 
Scheme 2. Proposed pathway of the intramolecular acylation reaction. 
The separation of (-)-5 and (-)-6 was difficult in a gram scale; 
therefore, the mixture of (-)-5 and (-)-6 was reacted with 
dibenzylamine in aza-Michael addition. Since the addition of the 
amine was found to be reversible, intermediate aminoketones 
were converted into tertiary aminodiol (-)-7 and aminoalcohol (-)-
8 by in situ reduction with NaBH4.[30] The two products obtained 
could easily be separated by column chromatography based on 
their different polarity. Hydrogenolysis of these compounds over 
Pd/C in MeOH afforded primary aminodiol (-)-9 and aminoalcohol 
(-)-10 in moderate yields (Scheme 3).[23,24] 
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Scheme 3. Stereoselective synthesis of limonene-based aminoalcohols and 
aminodiols. 
Subsequently, methylene ketone (-)-6, prepared in an optimized 
cyclisation reaction (Table 1) at 100 °C, was also reacted with 
amines to exploit the effect of ring system on the stereoselectivity 
of the addition obtaining tertiary and secondary aminoalcohols (-)-
8, (-)-11 and (-)-12 in highly stereoselective reactions (Scheme 4). 
 
Scheme 4. Stereoselective synthesis of aminoalcohols. 
The relative configuration of (-)-8, (-)-11 and (-)-12 was 
determined by NOESY spectral analysis. Clear NOE correlations 
were observed between H-6 and H-8, H-5, H-7, and between H-1 
and H-7. Therefore, the structure of 8, 11 and 12 was determined 
as presented in Figure 1. 
 
Figure 1. Determination of configuration (-)-8,11,12 by NOESY. 
The configurations of new stereogenic centers of (-)-7 were 
determined by NOESY, where noteworthy NOE effects were also 
observed between H-7 and H-8, H-1, H-6, as well as between H-
5 and H-6. The structure of (-)-7 was determined as shown in 
Figure 2. 
 
Figure 2. NOESY effects of the configuration of (-)-7. 
The synthesis of structural isomeric aminodiol (-)-13 was 
accomplished by hydroboration of compound (-)-8 by treatment 
with borane dimethyl sulfide followed by oxidation of the boron 
intermediate with hydrogen peroxide (Scheme 5). Note, that the 
addition resulted in two diastereoisomers of (-)-13 with a ratio of 
3:1 (based on NMR measurement of the crude product). Our 
efforts failed to isolate the minor compound, and only major 
product (-)-13 could be obtained after column chromatography. 
The configuration of the new stereogenic centers in (-)-13 was 
determined by NMR with NOESY experiments. Debenzylation 
with the H2/Pd/C system and purification of the crude product 
provided aminodiol (-)-14 in acceptable yield (Scheme 5). 
 
Scheme 5. Synthesis of 6-amino-1,4-diols. 
The NOESY experiments of (-)-13, where considerable NOE 
effects were observed between H-7 and H-1, H-6, between H-6 
and H-5, H-7, H-8, between H-5 and H-4, and between H-CH3 and 
H-3 (Figure 3). 
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Figure 3. Determination of the structure of aminodiol (-)-13 by NOESY. 
The procedure described above was repeated with (+)-limonene 
(+)-1 to obtain enantiomeric counterparts (+)-3 to (+)-14. 
Conclusions 
Starting from natural (+)- and (-)-limonene, new terpenoid bicyclic 
methylene ketones were obtained through an unexpected 
intramolecular acylation. The reaction pathway involves the 
formation of an acylium ion in the reaction of the carboxylic acid 
group with TFAA, followed by the attack of the electrophilic 
acylium ion moiety on the olefinic bond. The cyclisation was 
optimized for both products. Aza-Michael addition of secondary 
and primary amines on methylene ketones resulted in aminodiols 
and 1,3-aminoalcohols in highly stereoselective reactions. These 
compounds were used to prepare a new family of terpenoid 
aminoalcohols and aminodiols with high diastereoselectivity. 
Experimental Section 
General methods: 1H- and 13C-NMR were recorded on Bruker Avance 
DRX 400 spectrometer [400 MHz (1H) and 100 MHz (13C),  = 0 (TMS)]. 
Chemical shifts are expressed in ppm () relative to TMS as the internal 
reference. J values are given in Hz. Optical rotations were obtained with a 
Perkin-Elmer 341 polarimeter. Melting points were determined on a Kofler 
apparatus and are uncorrected. Microanalyses were performed on a 
Perkin-Elmer 2400 elemental analyser. Chromatographic separations 
were carried out on Merck Kiesegel 60 (230-400 mesh ASTM). Reactions 
were monitored with Merck Kieselgel 60 F254-precoated TLC plates (0.25 
mm thickness). 
Starting materials: (S)- and (R)-limonene [(-)- and (+)-1] are available 
commercially from Merck Co. All chemicals and solvents were used as 
supplied. THF and toluene were dried over Na wire. (S)- and (R)-isoperillyl 
alcohol [(-)-2 and (+)-2)] and (S)-and (R)-p-mentha-1,8-dien-9-al [(-)-3 and 
(+)-3] were prepared according to literature procedures, and all their 
spectroscopic data were similar as described.[20] 
(-)-(S)-p-Mentha-1,8-dien-9-oic acid ((-)-4): A solution of NaClO2 (5.6 g, 
61.9 mmol) and NaH2PO4 (6.8 g, 56.7 mmol) in water (40 mL) was added 
to the solution of (-)-3 (5.68 g, 37.8 mmol) and 2-methyl-2-butene (27.0 mL, 
255.0 mmol) in tert-BuOH (50.0 mL) at room temperature and the mixture 
was stirred for 12 h. The solution was then concentrated under reduced 
pressure and the residue was made alkaline with 10% aqueous NaOH 
solution (200 mL) and extracted with n-hexane (3 x 100 mL). The aqueous 
phase was acidified with 25% aqueous HCl solution (pH = 3-4) and 
extracted with Et2O (3 x 100 mL). The organic phase was dried (Na2SO4) 
and concentrated in vacuo. The crude product was purified with column 
chromatography on silica gel, eluting with n-hexane : EtOAc (4:1) followed 
by recrystallisation (n-hexane) affording 5.05 g (80%) compound (-)-4 as 
white crystals; m.p. 71-73 °C; [α]D20 = - 69 (c 0.27 MeOH); 1H-NMR (400 
MHz, CDCl3)  (ppm): 1.49-1.59 (m, 1H), 1.66 (s, 3H), 1.82-1.91 (m, 2H), 
1.93-1.98 (m, 1H), 2.06-2.12 (m, 1H), 2.22-2.26 (1H, m), 2.66-2.73 (1H, 
m), 5.40 (1H, s), 5.65 (s, 1H), 6.34 (s, 1H), 13C-NMR (100 MHz, CDCl3)  
(ppm) 23.5 (CH3), 28.4 (CH2), 30.4 (CH2), 31.4 (CH2), 34.7 (CH), 120.3 
(CH), 125.3 (CH2), 133.9 (Cq), 144.9 (Cq), 173.2 (C=O). C10H14O2 (166.22): 
calcd. C 72.26, H 8.49; found C 72.30, H 8.25 . 
(+)-(R)-p-Mentha-1,8-dien-9-oic acid ((+)-4): synthesized analogously to 
(-)-4 from (+)-3; [α]D20 = + 65 (c 0.27 MeOH). All spectroscopic data were 
similar to those of (-)-4. C10H14O2 (166.22): calcd. C 72.26, H 8.49; found 
C 72.34, H 8.32. 
General procedure for acetylation between olefin with carboxylic acid, 
using TFAA as catalyst. Method A: To solution of carboxylic acid (-)-4 
(3.1 g, 18.6 mmol) in dry toluene (70 mL) TFAA (8.0 mL, 57.5 mmol) was 
added at 0 °C. The resulting solution was stirred for 48 h at 0 °C, and the 
mixture was then diluted with toluene (100 mL), extracted with 10% 
aqueous NaOH solution (70 mL), and then with water (70 mL) and brine 
(70 mL). The organic layer was dried (Na2SO4), filtered, and concentrated. 
The crude product was subjected to column chromatography on silica gel 
(n-hexane/EtOAc = 19:1) to give a 67:33 mixture of (-)-5 and (-)-6 (2.37 g, 
80%). 
Method B: To solution of (-)-4 (2.0 g, 12.0 mmol) in dry toluene (45 mL) , 
TFAA (5.0 mL, 35.97 mmol) was added. The mixture was refluxed for 6 h. 
When completed, the reaction mixture was diluted with toluene (70 mL) 
and extracted with 10% aqueous NaOH solution (50 mL), next with water 
(50 mL), and with brine (50 mL). The organic layer was dried (Na2SO4), 
filtered, and concentrated. The crude product was subjected to column 
chromatography on silica gel (n-hexane/EtOAc = 19:1), resulting in 
compound (-)-6 (2.0 g, 56%). 
(-)-(1S,4S,5S)-4-Hydroxy-4-methyl-7-methylenebicyclo[3.2.1]octan-6-
one ((-)-5): yellow oil; [α]D20 = - 48 (c 0.495 MeOH); 1H-NMR (400 MHz, 
CDCl3)  (ppm) 1.48-1.57 (m, 1H), 1.64 (s, 3H), 1.71-1.76 (m, 1H), 1.83-
1.88 (m, 1H), 1.98-2.07 (m, 2H), 2.19 (dd, J = 5.1, 15.5 Hz, 1H), 3.13 (s, 
1H), 3.16-3.19 (m, 1H), 5.37 (s, 1H), 6.01 (s, 1H); 13C-NMR (100 MHz, 
CDCl3)  (ppm): 23.4 (CH3), 29.3 (CH2), 30.2 (CH2), 31.5 (CH2), 38.5 (CH), 
54.3 (CH), 87.9 (Cq), 116.4 (CH2), 147.9 (Cq), 203.5 (C=O). 
C10H14O2( 166.22): calcd. C 72.26; H 8.49; found C 72.35, H 8.30. 
(+)-(1R,4R,5R)-4-Hydroxy-4-methyl-7-methylenebicyclo[3.2.1]octan-
6-one ((+)-5): synthesized analogously to (-)-5 from (+)-4; [α]D20 = + 55 (c 
0.495 MeOH). All spectroscopic data were similar to those of (-)-5. 
C10H14O2 (166.22): calcd. C 72.26; H 8.49; found C 72.40, H 8.32. 
(-)-(1S,5S)-4-Methyl-7-methylenebicyclo[3.2.1]oct-3-en-6-one ((-)-6): 
yellow oil; [α]D20 = - 215 (c 0.315 MeOH ); 1H-NMR (400 MHz, CDCl3)  
(ppm): 1.75-1.78 (m, 4H), 1.90-1.95 (m, 1H), 2.02-2.06 (m, 1H), 2.55-2.62 
(m, 1H), 2.73 (d, J = 4.4 Hz, 1H), 3.06 (t, J = 5.4 Hz 1H), 5.36 (brs, 1H), 
5.47 (s, 1H), 5.94 (s, 1H); 13C-NMR (100 MHz, CDCl3)  (ppm): 22.6 (CH3), 
30.7 (CH2), 35.5 (CH2), 37.5 (CH), 51.8 (CH), 116.1 (CH2), 121.6 (CH), 
134.6 (Cq), 150.9 (Cq). C10H12O (148.20): calcd. C 81.04, H 8.16; found C 
81.00, H 8.20. 
(+)-(1R,5R)-4-Methyl-7-methylenebicyclo[3.2.1]oct-3-en-6-one ((+)-6): 
synthesized analogously to (-)-6 from (+)-4; [α]D20 = + 230 (c 0.315 MeOH). 
All spectroscopic data were similar to those of (-)-6. C10H12O (148.20): 
calcd. C 81.04, H 8.16, found C 81.11, H 8.23. 
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(-)-(1R,2S,5S,6R,7S)-6-((Dibenzylamino)methyl)-2-
methylbicyclo[3.2.1]octane-2,7-diol ((-)-7) and (-)-(1S,5S,6R,7R)-7-
((Dibenzylamino)methyl)-4-methylbicyclo[3.2.1]oct-3-en-6-ol ((-)-8): A 
mixture of acylation products (-)-5 and (-)-6 based on Method A (2.7 g) 
was mixed with dibenzylamine (9.0 mL, 46.8 mmol) in neat. The mixture 
was stirred for 20 h at room temperature. When completed (indicated by 
TLC), the mixture was dissolved in the mixture of dry EtOH (40 mL) and 
water (5 mL) and cooled to 0 °C. Solid NaBH4 (2.7 g, 71.4 mmol) was 
added to the mixture in small portions followed by stirring overnight in ice 
bath. The mixture was then quenched with water (100 mL) and extracted 
with CH2Cl2 (3 x 100 mL). The organic phase was dried (Na2SO4) and 
evaporated in vacuo. The crude product was purified by column 
chromatography on silica gel (n-hexane/EtOAc = 19:1 to 2:1), resulting in 
2.0 g (50 %) of compound (-)-7 and 0.58 g (30 %) of compound (-)-8. 
Compound (-)-7: white crystals; m.p. 108-183 °C; [α]D20 = - 14 (c 0.25 
MeOH); 1H-NMR (400 MHz, CDCl3)  (ppm) 1.09 (dd, J = 6.6, 14.3 Hz, 1H), 
1.16-1.22 (m, 2H), 1.26 (s, 3H), 1.28-1.36 (m, 1H), 1.57-1.62 (m, 1H), 1.91 
(brs, 1H), 2.04-2.08 (m, 2H), 2.36-2.42 (m, 2H), 2.95 (t, 13.8 Hz, 1H), 3.21 
(d, J = 13.1 Hz, 2H), 3.98 (d, J = 13.1 Hz, 2H), 4.47 (dd, J = 6.6, 9.4 Hz, 
1H), 7.24-7.34 (m, 10H) ; 13C-NMR (100 MHz, CDCl3)  (ppm): 24.2 (CH2), 
31.0 (CH3), 31.9 (CH2), 32.5 (CH2), 36.3 (CH), 39.0 (CH), 50.7 (CH), 52.3 
(CH2), 58.6 (CH2) 72.7 (Cq), 73.7 (Cq), 127.3 (CH), 128.6 (CH), 129.5 (CH), 
138.0 (Cq). C24H31NO2 (365.51): calcd. C 78.86, H 8.55, N 3.83; found C 
78.68, H 8.60, N 3.60. Compound (-)-8: white crystals; m.p. 165-169 °C; 
[α]D20 = -63 (c 0.29 MeOH); 1H-NMR (400 MHz, CDCl3)  (ppm) 1.51-1.56 
(m, 1H), 1.61-1.64 (m, 4H), 1.79-1.83 (d, J = 17.8 Hz, 1H), 2.07-2.12 (m, 
1H), 2.20 (q, J = 4.7, 6.0 Hz, 1H), 2.28 (t, J = 4.4 Hz, 1H), 2.36-2.42 (m, 
1H), 2.48 (dd, J = 5.2, 11.9 Hz, 1H), 2.93 (t, J = 12.0 Hz, 1H), 3.42 (d, J = 
13.6 Hz, 2H), 3.77 (d, J = 13.6 Hz, 2H), 4.31 (dd, J = 5.7, 9.3 Hz, 1H), 5.02 
(s, 1H), 7.23-7.32 (m, 10H); 13C-NMR (100 MHz, CDCl3)  (ppm): 25.1 
(CH3), 29.8 (CH2), 32.5 (CH2), 36.2 (CH), 38.9 (CH), 45.4 (CH), 54.6 (CH2), 
58.0 (CH2), 78.3 (CH), 117.8 (CH), 127.3 (CH), 128.4 (CH), 129.6 (CH), 
137.8 (Cq), 140.3 (Cq). C24H29NO (347.49): calcd. C 82.95, H 8.41, N 4.03; 
found C 82.75, H 8.22, N 4.05. 
(+)-(1S,2R,5R,6S,7R)-6-((Dibenzylamino)methyl)-2-
methylbicyclo[3.2.1]octane-2,7-diol ((+)-7): synthesized analogously to 
(-)-7 from the mixture of (+)-5 and (+)-6; [α]D20 = + 13 (c 0.25 MeOH). All 
spectroscopic data were similar to those of (-)-7. C24H31NO2 (365.51): 
calcd. C 78.86, H 8.55, N 3.83; found C 78.70, H 8.68, N 3.73. 
(+)-(1R,5R,6S,7S)-7-((Dibenzylamino)methyl)-4-
methylbicyclo[3.2.1]oct-3-en-6-ol ((+)-8): synthesized analogously to (-)-
8 from the mixture of (+)-5 and (+)-6; [α]D20 = + 58 (c 0.29 MeOH). All 
spectroscopic data were similar to those of (+)-8. C24H29NO (347.49): calcd. 
C 82.95, H 8.41, N 4.03; found C 82.78, H 8.49, N 3.98. 
General procedure for preparation of conjugate addition with primary 
amines: Compound (-)-6 obtained by method B (2.7 g, 18.2 mmol) was 
stirred with (R)-methylbenzylamine or (S)-methylbenzylamine (6.0 mL, 
46.8 mmol) in neat for 20 h at room temperature. When the reaction was 
completed (indicated by TLC), the mixture was dissolved in the mixture of 
dry EtOH (40 mL) and water (5 mL) and cooled to 0 °C. Solid NaBH4 (2.7 
g, 71.4 mmol) was added to the mixture in small portions and stirred 
overnight in an ice bath. The mixture was then quenched with water (100 
mL) and extracted with CH2Cl2 (3 x 100 mL). The organic phases were 
combined and washed with 5% aqueous HCl solution (100 mL), then dried 
(Na2SO4) and evaporated in vacuo. The crude product was purified by 
recrystallisation (n-hexane/CH2Cl2), resulting in compounds (-)-11 and (-)-
12, respectively. 
(-)-(1S,5S,6R,7R)-4-Methyl-7-((((R)-1-
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-3-en-6-ol ((-)-11): 1.48 g 
(30%); white crystals; m.p. 108-185 °C; [α]D20 = - 71 (c 0.27 MeOH); 1.48-
1.64 (m, 4H), 1.73 (s, 3H), 1.93 (d, J = 6.2 Hz, 3H), 2.08 (d, J = 17.8 Hz, 
3H), 2.30 (br s, 2H), 2.67 (br s, 2H), 2.97 (q, 1H), 4.25 (br s, 1H), 4.65 (br 
s, 1H), 5.13 (s, 1H), 7.37-7.45 (m, 3H), 7.65-7.67 (m, 2H), 8.64 (br s, 1H), 
9.79 (br s, 1H); 13C-NMR (100 MHz, CDCl3)  (ppm): 23.9 (CH3), 25.3 
(CH3), 29.9 (CH2), 32.6 (CH2), 36.0 (CH), 43.7 (CH), 45.0 (CH), 47.2 (CH2), 
58.8 (CH), 77.7 (CH), 118.4 (CH), 126.5 (CH), 127.3 (CH), 128.7 (CH), 
139.8 (Cq), 144.9 (Cq). C18H25NO (271.40): calcd. C 79.66, H 9.28, N 5.16; 
found C 79.60, H 9.12, N 5.03. 
(+)-(1R,5R,6S,7S)-4-Methyl-7-((((S)-1- 
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-3-en-6-ol ((+)-11) 
synthesized analogously to (-)-11; [α]D20 = + 76 (c 0.27 MeOH). All 
spectroscopic data were similar to those of (-)-11. C18H25NO (271.40): 
calcd. C 79.66, H 9.28, N 5.16; found C 79.73, H 9.38, N 4.91.  
(-)-(1S,5S,6R,7R)-4-Methyl-7-((((S)-1- 
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-3-en-6-ol ((-)-12): 1.04 g 
(21%); white crystals; m.p. 108-184 °C; [α]D20 = -131 (c 0.34 MeOH); 1H-
NMR (400 MHz, CDCl3)  (ppm) 1.50-1.55 (m, 1H), 1.61 (d, J = 13.9 Hz, 
2H), 1.63 (s, 3H), 1.87 (d, J = 6.8 Hz, 3H), 2.07-2.12 (m, 1H), 2.24-2.31 
(m, 2H), 2.69-2.79 (m, 2H), 2.98 (q, 1H), 4.27-4.30 (m, 1H), 4.57 (dd, J = 
5.9, 9.2 Hz, 1H), 5.00 (s, 1H), 7.35-7.44 (m, 3H), 7.52-7.55 (m, 2H), 8.56 
(br s, 1H), 9.79 (br s, 1H) ; 13C-NMR (100 MHz, CDCl3)  (ppm): 20.1 (CH3), 
24.9 (CH3), 29.5 (CH2), 32.5 (CH2), 36.2 (CH), 40.0 (CH), 44.8 (CH), 45.2 
(CH2), 49.2 (CH), 75.0 (CH), 117.4 (CH), 127.9 (CH), 129.2 (CH), 129.3 
(CH), 135.9 (Cq), 139.9 (Cq). C18H25NO (271.40): calcd C 79.66, H 9.28, N 
5.16; found C 79.52, H 9.13, N 5.02. 
(+)-(1R,5R,6S,7S)-4-Methyl-7-((((R)-1-
phenylethyl)amino)methyl)bicyclo[3.2.1]oct-3-en-6-ol ((+)-12): 
synthesized analogously to (-)-12; [α]D20 = + 141.7 (c 0.34 MeOH). All 
spectroscopic data were similar to those of (-)-12. C18H25NO (271.40): 
calcd. C 79.66, H 9.28, N 5.16; found C 79.73, H 9.31, N 4.93. 
(-)-(1R,3S,4S,5S,6R,7R)-7-((Dibenzylamino)methyl)-4-
methylbicyclo[3.2.1]octane-3,6-diol ((-)-13): To the cooled (0 °C) 
solution of (-)-8 (1 g, 2.88 mmmol) in dry THF (30 mL) was added 
(CH3)2S.BH3 (700 µL) under the argon atmosphere. The mixture was 
stirred overnight at room temperature. The resulting solution then was 
treated with 3M aqueous NaOH (3 mL) and 30% aqueous hydrogen 
peroxide solution (3 mL) diluted in dry EtOH (10 mL). The mixture was 
stirred for 1.5 h at room temperature and then it was diluted with EtOAc 
(100 mL) and extracted with water (3 x 100 mL). The organic phase was 
dried (Na2SO4), filtered and concentrated under reduce pressure. The 
crude product obtained was purified by chromatography on silica gel (n-
hexane/EtOAc = 9:1 to 2: 1 as eluent), resulting in 0.45 g (43%) of (-)-13  
as white crystals; m.p. 191-193 °C; [α]D20 = -14 (c 0.26 MeOH); 1H-NMR 
(400 MHz, CDCl3)  (ppm) 1.10 (d, J = 6.9 Hz, 3H), 1.26-1.46 (m, 5H), 
1.76-1.83 (m, 1H), 2.00-2.05 (m, 1H), 2.20-2.23 (m, 1H), 2.30-2.37 (m, 1H), 
2.41 (dd, J = 5.3, 12.4 Hz, 1H), 3.02 (t, J = 12.6 Hz, 1H), 3.28 (d, J = 12.8 
Hz, 2H), 3.44-3.51 (m, 1H), 3.94 (d, J = 13.1 Hz, 2H), 4.47 (dd, J = 6.6, 9.5 
Hz), 7.25-7.35 (m, 10H); 13C-NMR (100 MHz, CDCl3)  (ppm) : 17.8 (CH3), 
37.1 (CH2), 38.0 (CH), 38.5 (CH2), 40.2 (CH), 45.5 (Cq), 45.7 (CH), 51.1 
(CH2), 58.5 (CH2), 70.9 (CH), 75.6 (CH), 127.6 (CH), 128.6 (CH), 129.6 
(CH). C24H31NO2 (365.51): calcd. C 77.86, H 8.55, N 3.83; found C 77.70, 
H 8.50, N 3.62. 
(+)-(1S,3R,4R,5S,6S,7S)-7-((Dibenzylamino)methyl)-4-
methylbicyclo[3.2.1]octane-3,6-diol ((+)-13): synthesized analogously 
to (-)-13; [α]D20 = + 16 (c 0.26 MeOH). All spectroscopic data were similar 
to those of (-)-13. C24H31NO2 (365.51): calcd. C 77.86, H 8.55, N 3.83; 
found C 77.93, H 8.62, N 3.87. 
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General procedure for debenzylation and crystallisation of 
aminodiols (-)-7 or (-)-13: A solution of aminodiols (-)-7 or (-)-13 (1.05 g, 
2.88 mmol) in MeOH (5 mL) was added to a suspension of 5% Pd/C (225 
mg) in MeOH (30 mL). The mixture was stirred under H2 atmosphere for 
12 h at room temperature. After the reaction was completed (monitored by 
means of TLC), the mixture filtered through a pad of Celite and the solvent 
was removed by reduced pressure. The crude product crystallized in Et2O, 
resulting (-)-9 or (-)-14 as white crystals. 
(-)-(1S,2R,5R,6S,7R)-6-(Aminomethyl)-2-methylbicyclo[3.2.1]octane-
2,7-diol ((-)-9): 0.26 g (49%) ; white crystals; m.p. 210-220 °C; [α]D20 =  -
31 (c 0.22 MeOH); 1H-NMR (400 MHz, DMSO-d6)  (ppm) 1.05-1.10 (m, 
1H), 1.15-1.24 (m, 4H), 1.34 (d, J = 9.3 Hz, 1H), 1.54-1.62 (m, 2H), 1.85-
1.90 (m, 1H), 1.96 (s, 1H), 2.11 (d, J = 11.4 Hz, 1H), 2.13-2.19 (m, 1H), 
2.71 (dd, J = 6.4, 12.6 Hz, 1H), 2.97 (dd, J = 8.5, 12.6 Hz, 1H), 3.20-3.60 
(brs, 4H), 4.38 (dd, J = 6.6, 10.4 Hz, 1H); 13C-NMR (100 MHz, DMSO-d6) 
 (ppm): 23.4 (CH2), 30.9 (CH3), 31.0 (CH2), 32.7 (CH2), 35.1 (CH), 36.9 
(CH2), 42.0 (CH), 50.0 (CH), 70.3 (Cq), 70.5 (CH). C10H19NO2 (185.26): 
calcd. C 64.83, H 10.34, N 7.56; found C 64.85, H 10.30, N 7.47. 
(+)-(1R,2S,5S,6R,7S)-6-(Aminomethyl)-2-methylbicyclo[3.2.1]octane-
2,7-diol ((+)-9): synthesized analogously to (-)-9 from (+)-7; [α]D20 = + 33 
(c 0.22 MeOH). All spectroscopic data were similar to those of (-)-9. 
C10H19NO2 (185.26): calcd. C 64.83, H 10.34, N 7.56; found C 64.89, H 
10.38, N 7.39. 
(-)-(1R,3S,4S,5S,6R,7R)-7-(Aminomethyl)-4-
methylbicyclo[3.2.1]octane-3,6-diol ((-)-14): 0.37 g (70%); white 
crystals; m.p. 230-235 °C; [α]D20 = -16 (c 0.25 MeOH); 1H-NMR (400 MHz, 
DMSO-d6)  (ppm) 1.10 (d, J = 6.9 Hz, 3H), 1.21-1.44 (m, 4H), 1.81-1.85 
(m, 1H), 2.03-2.17 (m, 3H), 2.71-2.76 (m, 1H), 2.97-3.03 (m, 1H), 3.59-
3.65 (m, 1H), 4.24 (d, J = 5.5 Hz, 1H), 4.40 (quin, 1H), 5.00 (d, J = 5.5 Hz, 
1H), 7.94 (br s, 3H); 13C-NMR (100 MHz, DMSO-d6)  (ppm): 17.9 (CH3), 
35.8 (CH2), 36.8 (CH), 37.1 (CH2), 37.7 (CH2), 42.3 (CH), 44.5 (CH), 45.3 
(CH), 68.6 (CH), 72.1 (CH). C10H19NO2 (185.26): calcd. C 64.83, H 10.34, 
N 7.56; found C 64.63, H 10.20, N 7.66. 
(+)-(1S,3R,4R,5R,6S,7S)-7-(Aminomethyl)-4-
methylbicyclo[3.2.1]octane-3,6-diol ((+)-14): synthesized analogously 
to (-)-14 from (+)-13; [α]D20 = + 19 (c 0.25 MeOH). All the spectroscopic 
data were similar to those of (-)-14. C10H19NO2 (185.26): calcd. C 64.83, H 
10.34, N 7.56; found: C 64.75, H 10.23, N 7.69. 
Procedure for the debenzylation  and crystallisation of compound (-)-
8, (-)-11 or (-)-12: To a suspension of palladium-on-carbon (5% Pd/C, 225 
mg) in MeOH (30 mL), the tertiary aminoalcohol (-)-8 (1.00, 2.88 mmol) or 
secondary aminoalcohol (-)-11 or (-)-12 (0.78, 2.88 mmol) was added, and 
the mixture was stirred under a H2 atmosphere at room temperature and 
normal pressure for 8 h. When the reaction completed, the mixture was 
filtered through a Celite pad and the solution was evaporated to dryness. 
The crude product crystallized in Et2O, resulting in the formation of 
compound (-)-10 (0.34 g, 70%). 
(-)-(1S,5S,6R,7R)-7-(Aminomethyl)-4-methylbicyclo[3.2.1]oct-3-en-6-
ol ((-)-10): 0.34 g (70%) ; white crystals; m.p. 191-193 °C; [α]D20 = -188 (c 
0.25 MeOH); 1H-NMR (400 MHz, DMSO-d6)  (ppm) 1.53-1.61 (m, 2H), 
1.65 (d, J = 1.3 Hz, 3H), 1.87 (d, J = 18.2 Hz, 1H), 2.10-2.17 (m, 2H), 2.28-
2.34 (m, 2H), 2.70-2.77 (m, 1H), 2.86-2.95 (m, 1H), 4.31-4.36 (m, 1H), 5.10 
(d, J = 4.8 Hz, 1H), 5.15 (s, 1H), 7.74 (br s, 3H); 13C-NMR (100 MHz, 
DMSO-d6)  (ppm): 24.9 (CH3), 29.1 (CH2), 31.6 (CH2), 34.6 (CH), 37.9 
(CH2), 40.9 (CH), 44.6 (CH), 75.3 (CH), 117.3 (CH), 139.3 (Cq). C10H17NO 
(167.25): calcd. C 71.81, H 10.25, N 8.37; found C 71.63, H 10.20, N 8.15. 
(+)-(1R,5R,6S,7S)-7-(Aminomethyl)-4-methylbicyclo[3.2.1]oct-3-en-6-
ol ((+)-10): synthesized analogously to (-)-10 ; [α]D20 = + 223 (c 0.25 
MeOH). All the spectroscopic data were similar to those of (-)-10. 
C10H17NO (167.25): calcd. C 71.81, H 10.25, N 8.37; found C 71.89, H 
10.36, N 8.21. 
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